🔗 Share this article

The top legal official in Texas Paxton is taking legal action against the manufacturers of acetaminophen, alleging the firms hid potential risks that the pain reliever created to children's cognitive development.

This legal action arrives four weeks after Former President Trump advocated an unproven link between consuming acetaminophen - also known as paracetamol - during pregnancy and autism spectrum disorder in offspring.

The attorney general is filing suit against Johnson & Johnson, which once produced the medication, the exclusive pain medication recommended for pregnant women, and the current manufacturer, which currently produces it.

In a statement, he stated they "deceived the public by gaining financially from suffering and pushing pills without regard for the risks."

The company asserts there is no credible evidence connecting acetaminophen to autism spectrum disorder.

"These companies deceived for years, knowingly endangering millions to line their pockets," Paxton, a Republican, declared.

The manufacturer said in a statement that it was "deeply concerned by the dissemination of inaccurate information on the reliability of acetaminophen and the likely effects that could have on the health of women and children in America."

On its official site, the company also stated it had "continuously evaluated the pertinent research and there is insufficient valid information that indicates a verified association between consuming paracetamol and autism spectrum disorder."

Organizations acting on behalf of physicians and health professionals share this view.

ACOG has stated paracetamol - the primary component in acetaminophen - is a restricted selection for pregnant women to treat discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of studies on the consumption of paracetamol in pregnancy, not a single reputable study has conclusively proven that the consumption of acetaminophen in any trimester of gestation results in brain development issues in offspring," the association stated.

The lawsuit references latest statements from the Trump administration in claiming the medication is allegedly unsafe.

In recent weeks, the former president raised alarms from health experts when he instructed women during pregnancy to "resist strongly" not to consume acetaminophen when sick.

The US Food and Drug Administration then issued a notice that medical professionals should think about restricting the use of acetaminophen, while also stating that "a causal relationship" between the medication and autism in children has not been established.

Health Secretary RFK Jr, who oversees the FDA, had promised in April to conduct "a massive testing and research effort" that would determine the source of autism spectrum disorder in a matter of months.

But experts warned that identifying a single cause of autism spectrum disorder - thought by researchers to be the result of a complex mix of inherited and environmental factors - would be difficult.

Autism is a category of enduring cognitive variation and disability that affects how individuals encounter and interact with the world, and is identified using doctors' observations.

In his legal document, Paxton - who supports Trump who is seeking the Senate - claims Kenvue and Johnson & Johnson "willfully ignored and attempted to silence the research" around paracetamol and autism.

The case aims to force the firms "destroy any marketing or advertising" that claims acetaminophen is secure for pregnant women.

The court case mirrors the concerns of a assembly of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who filed suit against the makers of acetaminophen in 2022.

A federal judge threw out the legal action, saying research from the plaintiffs' authorities was inconclusive.